Faced with the resurgence of cases of chlamydiosis and gonococcalia, sexually transmitted diseases (MST), health insurance announced on Monday 30 June the launch of a screening kit by autoprender. Free and delivered to your home, it will be accessible to young people aged 18 to 25.
Available from 1is July for women, the online order of the kit will be extended to men “During the second half”according to a press release from the National Health Insurance Fund (CNAM). After a “ Quick questionnaire for ten questions », The request can be made directly on the Ameli website, used for all the health insurance procedures.
This kit, which will be delivered “At the place of his choice », Will have to be returned with the tube containing the approval in a laboratory. “The young [sera] warned of the availability of its results by SMS within five working days ”specifies health insurance.
Chlamydiosis and gonococcal infections can be treated, but the lack of care can lead to complications. These bacterial sexually transmitted infections (IST) have been increasing continuously since the 2000s, to the point of being “A public health issue due to the serious risks that they present both for women and for men”like infertility or the risk of extra-uterine pregnancy, underlines the government agency. The European Disease Prevention and Control Center had alerted, on March 7, 2024, to a “Disturbing wave” and the “Urgent need to increase awareness”.
An operation in the wake of “My IST test”
Between 2021 and 2023, the cases of gonorrhea jumped 59 % in men and 46 % in women, while cases of chlamydiosis increased by 10 % in men, according to Public Health France. “Even in the absence of a symptom”it is possible to carry an STI “And to transmit it”recalled the organization, before clarifying that “This is why screening is an essential tool for combating the dissemination of these diseases.”
The launch of this kit is part of “My IST test”, which has allowed those under 26, since September 2024, to be tested for free and without prescription in all medical analysis laboratories for four infections: Chlamydia trachomatis, gonococcus, syphilis and hepatitis B.
According to health insurance, sending an autoprender kit has already shown its effectiveness during the “Chlamyweb” experimentation led in 2012 by the National Institute for Prevention and Health Education.
This system had increased “By 3.4 the use of chlamydiae screening in young people compared to an orientation towards the care system” (General practitioners, gynecologists, free information, screening and diagnostic centers, etc.).
